Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection

NCT06998043 is registered in ClinicalTrials.gov with BiomX Ltd as lead sponsor.

NCT NCT06998043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06998043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection
Lead sponsor
BiomX Ltd
Phase
Phase 2
Overall status
Recruiting
Start date
July 2, 2025
Completion date
September 30, 2026
Enrollment
63 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pseudomonas aeruginosa infection, cystic fibrosis (cf)